Covid-19: Joint statement from the ABS & UKBCG on Neoadjuvant Chemotherapy

The UKBCG and ABS released a joint statement on neoadjuvant chemotherapy during the Covid-19 pandemic

Classifications: Service Guidance

Keywords: Neoadjuvant Chemotherapy/ NACT COVID-19